Cargando…

Preface: Focus on complex metallic phases

Detalles Bibliográficos
Autores principales:	Tsai, An-Pang, Grin, Yuri, de Boissieu, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2014
Materias:	Focus on Complex Metallic Phases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099670/ https://www.ncbi.nlm.nih.gov/pubmed/27877709 http://dx.doi.org/10.1088/1468-6996/15/5/050301

Ejemplares similares

Foreword: Focus on complex metallic phases
por: Shechtman, Dan
Publicado: (2014)

Intermetallic compounds in heterogeneous catalysis—a quickly developing field
por: Armbrüster, Marc, et al.
Publicado: (2014)

Complex metallic alloys as new materials for additive manufacturing
por: Kenzari, Samuel, et al.
Publicado: (2014)

Friction and solid-solid adhesion on complex metallic alloys
por: Dubois, Jean-Marie, et al.
Publicado: (2014)

Surfaces of Al-based complex metallic alloys: atomic structure, thin film growth and reactivity
por: Ledieu, Julian, et al.
Publicado: (2014)

Activation of Al–Cu–Fe quasicrystalline surface: fabrication of a fine nanocomposite layer with high catalytic performance
por: Kameoka, Satoshi, et al.
Publicado: (2014)

Metallic–covalent bonding conversion and thermoelectric properties of Al-based icosahedral quasicrystals and approximants
por: Takagiwa, Yoshiki, et al.
Publicado: (2014)

Deformation at ambient and high temperature of in situ Laves phases-ferrite composites
por: Donnadieu, Patricia, et al.
Publicado: (2014)

Tailoring microstructure of Mg–Zn–Y alloys with quasicrystal and related phases for high mechanical strength
por: Singh, Alok
Publicado: (2014)

Quasicrystal-reinforced Mg alloys
por: Kyun Kim, Young, et al.
Publicado: (2014)

Photonic crystals, amorphous materials, and quasicrystals
por: Edagawa, Keiichi
Publicado: (2014)

Magnetism in icosahedral quasicrystals: current status and open questions
por: Goldman, Alan I
Publicado: (2014)

Very large thermal rectification in bulk composites consisting partly of icosahedral quasicrystals
por: Takeuchi, Tsunehiro
Publicado: (2014)

Intermetallic compounds in heterogeneous catalysis
por: Armbrüster, Marc, et al.
Publicado: (2020)

Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease
por: Yau, Thomas, et al.
Publicado: (2012)

A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma
por: Yau, Thomas, et al.
Publicado: (2012)

Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer
por: Horinouchi, Hidehito, et al.
Publicado: (2015)

A phase Ib study of everolimus combined with metformin for patients with advanced cancer
por: Molenaar, Remco J., et al.
Publicado: (2017)

Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)
por: Keizer, Ron J., et al.
Publicado: (2011)

Ferrocene derivatives with planar chirality and their enantioseparation by liquid‐phase techniques
por: Peluso, Paola, et al.
Publicado: (2022)

Eribulin mesylate in patients with refractory cancers: a Phase I study
por: Mukohara, Toru, et al.
Publicado: (2011)

Patient-Reported Physician Treatment Recommendations and Compliance Among U.S. Adults with Low Back Pain
por: Goertz, Christine M., et al.
Publicado: (2021)

Phase II study of sunitinib as second-line treatment for advanced gastric cancer
por: Bang, Yung-Jue, et al.
Publicado: (2010)

A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors
por: Joerger, Markus, et al.
Publicado: (2019)

Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors
por: Puzanov, Igor, et al.
Publicado: (2014)

Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokinetics
por: Nwankwo, Nwabundo, et al.
Publicado: (2012)

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics
por: Sunakawa, Yu, et al.
Publicado: (2013)

Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies
por: Smith, David C., et al.
Publicado: (2015)

Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer
por: van der Noll, R., et al.
Publicado: (2015)

Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma
por: Gluck, W. Larry, et al.
Publicado: (2019)

Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors
por: Annunziata, Christina M., et al.
Publicado: (2012)

Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumors
por: Naing, Aung, et al.
Publicado: (2013)

Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer
por: Tolaney, Sara M., et al.
Publicado: (2015)

Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors
por: Yamamoto, Noboru, et al.
Publicado: (2016)

Phase 1 study of the MDM2 antagonist RO6839921 in patients with acute myeloid leukemia
por: Uy, Geoffrey L., et al.
Publicado: (2020)

Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I study
por: Olmedo, María Eugenia, et al.
Publicado: (2021)

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer
por: Boku, Narikazu, et al.
Publicado: (2013)

Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor
por: Ito, Tetsuhide, et al.
Publicado: (2013)

Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer
por: Doi, Toshihiko, et al.
Publicado: (2015)

Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors
por: Ito, Tetsuhide, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d1mbsu6p3feu4if62va45rc9k7